FNDC5 and neoplasm: It is not clear, whether the altered expression of irisin, observed in tumor tissue is the cause of tumorigenesis, or a compensatory mechanism to combat tumorigenesis [19], implying that more in vivo studies are required to render irisin as a marker for cancer diagnosis, prognosis or treatment.